Concepedia

Endocannabinoids Measurement in Human Saliva as Potential Biomarker of Obesity

Isabel Matias, Blandine Gatta‐Cherifi, Antoine Tabarin, Samantha Clark, Thierry Lesté-Lasserre, Giovanni Marsicano, Pier Vincenzo Piazza, Daniela Cota

PLoS ONE · 2012 · 135 citations · 34 references

DOIFull text

Open access

Abstract

Endocannabinoids and N-acylethanolamines are quantifiable in saliva and their levels correlate with obesity but not with feeding status. Body weight loss significantly decreases salivary AEA, which might represent a useful biomarker in obesity.

References

34

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

Jaakko Tuomilehto, Jaana Lindström, Johan G. Eriksson et al. · New England Journal of Medicine · 2001 · 10.8K citations · Full text

Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners

Yasuo Okamoto, Jun Morishita, Kazuhito Tsuboi et al. · Journal of Biological Chemistry · 2004 · 797 citations · Full text

Activation of the Peripheral Endocannabinoid System in Human Obesity

Stefan Engeli, Jana Böhnke, M Feldpausch et al. · Diabetes · 2005 · 685 citations · Full text

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia

Isabel Matias, Marie‐Paule Gonthier, Pierangelo Orlando et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 649 citations

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men

M. Côté, Isabel Matias, Isabelle Lemieux et al. · International Journal of Obesity · 2007 · 377 citations

, , +9